RTOG 0518: Randomized Phase III Trial to Evaluate Zoledronic Acid for Prevention of Osteoporosis and Associated Fractures in Prostate Cancer Patients

BACKGROUND: RTOG 0518 evaluated the potential benefit of zoledronic acid therapy in preventing bone fractures for patients with high grade and/or locally advanced, non-metastatic prostate adenocarcinoma receiving luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy (RT). METHODS: El...

Descripción completa

Detalles Bibliográficos
Autores principales: Kachnic, Lisa A., Pugh, Stephanie L, Tai, Patricia, Smith, Matthew, Gore, Elizabeth, Shah, Amit B., Martin, Andre-Guy, Kim, Harold E., Nabid, Abdenour, Lawton, Colleen AF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830691/
https://www.ncbi.nlm.nih.gov/pubmed/24080992
http://dx.doi.org/10.1038/pcan.2013.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830691/
https://www.ncbi.nlm.nih.gov/pubmed/24080992
http://dx.doi.org/10.1038/pcan.2013.35

Ejemplares similares